Development of a colorectal cancer screening intervention for Alaska Native people during a pandemic year

Flanagan, Christie A.; Rutten, Lila J. Finney; Kisiel, John B.; Lent, Jennifer K.; Bachtold, Joseph F.; Swartz, Andrew W.; Redwood, Diana

doi:10.1016/j.conctc.2022.101016

Cited by 3 publications

(3 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Alaska Native Tribal health organizations, collectively called the Alaska Tribal Health System, have recognized colorectal cancer (CRC) as a major health priority and as a result have focused substantial attention on increasing awareness of, access to, and use of CRC screening [1][2][3]. This focus is driven by the disproportionately high incidence of CRC among Alaska Native peoples [4], who also have a high prevalence of precancerous colorectal polyps [5,6].…”

Section: Introductionmentioning

confidence: 99%

Clinical Outcomes from the Alaska Native Tribal Health Consortium Colorectal Cancer Control Program: 2009–2015

Nash,

Verhage,

Flanagan

et al. 2024

IJERPH

Self Cite

View full text Add to dashboard Cite

The Alaska Native Tribal Health Consortium (ANTHC) participated in the United States Centers for Disease Control and Prevention Colorectal Cancer Control Program (CRCCP) from 2009 to 2015. We conducted a descriptive evaluation of ANTHC CRCCP demographics, quality measures, and clinical outcomes, including screening methods employed within the program and screening outcomes. There were 6981 program screenings completed, with the majority (81.3%) of people screened in the 50–75 year age group. Colonoscopy was the primary screening test used, accounting for 6704 (96.9%) of the screening tests. Quality of colonoscopy was high: adequate bowel preparation was reported in 98.2% of colonoscopies, cecal intubation rate was 98.9%, and the adenoma detection rate was 38.9%. A high proportion (58.9%) of colonoscopies had an initial finding of polyps or lesions suspicious for cancer; 41.2% of all colonoscopies had histological confirmation of either adenomatous polyps (40.6%) or cancer (0.5%). The ANTHC CRCCP successfully increased CRC screening among American Indian and Alaska Native peoples living in Alaska; this was achieved primarily through high-quality colonoscopy metrics. These data support a continued focus by the Alaska Native Tribal Health Consortium and its tribal health partners on increasing CRC screening and reducing cancer mortality among Alaska Native peoples.

show abstract

Section: Introductionmentioning

confidence: 99%

Clinical Outcomes from the Alaska Native Tribal Health Consortium Colorectal Cancer Control Program: 2009–2015

Nash,

Verhage,

Flanagan

et al. 2024

IJERPH

Self Cite

View full text Add to dashboard Cite

show abstract

“…The FAIT performed better than the colonoscopy as the initial test(6). Other modalities, such as faecal DNA, are nevertheless employed in the event that efforts to provide the standard screening issue are hampered (7).…”

Section: Introductionmentioning

confidence: 99%

Colorectal cancer screening future modalities among Saudi population: national questioner

Alharbi

2023

Preprint

View full text Add to dashboard Cite

Background: Understanding how the general public feels about the method of colorectal cancer screening is crucial since early diagnosis of cancer through the colorectal cancer screening program lowers mortality rates. Methods: The purpose of this study was to determine the most popular technique of colorectal cancer screening in Saudi Arabia. From September 2021 to February 2022, a cross-sectional study using an adult Saudi population was undertaken. On an internet platform, a self-created survey was given to the general public. All statistical analyses were carried out using SPSS version 26 and data were tabulated using Google Forms. Results: out of 10781 participants were analysed, out of them ,we found 5612 are suitable for analysis between colonoscopy and faecal immunochemical test (FAIT) population preference for colorectal cancer screening modalities. we found that gender, employment and age were important predicators for the preferred screening modality. Conclusion: More attention should be paid to the population's preferred method of colorectal cancer screening, which could increase the success of the screening effort.

show abstract

“…The study design was guided by the Reach Effectiveness Adoption Implementation Maintenance (RE-AIM) framework [15][16][17][18]. The overall study goal is to identify feasible and culturally appropriate solutions for promoting CRC screening uptake and to inform community and healthcare system efforts to reduce CRC among the Alaska Native population.…”

Section: Introductionmentioning

confidence: 99%

Provider- and System-Level Barriers and Facilitators to Colonoscopy and Multi-Target Stool DNA for Colorectal Cancer Screening in Rural/Remote Alaska Native Communities

Redwood,

Toffolon,

Flanagan

et al. 2023

IJERPH

Self Cite

View full text Add to dashboard Cite

The Alaska Tribal Health System is working to increase colorectal cancer (CRC) screening among Alaska Native people, who experience the highest CRC rates in the world. This study examined CRC screening provider- and system-level barriers and facilitators from the perspective of healthcare providers serving Alaska Native people in rural/remote communities. A total of 28 provider (physicians, advanced practice, and Community Health Aides/Practitioners) interviews were held from 1 February to 30 November 2021. Colonoscopy provider-level barrier themes included time, competing priorities, and staffing, while system-level barriers included travel costs, weather, and the COVID-19 pandemic. Multi-target stool DNA (mt-sDNA) barrier themes included test viability and unfamiliarity, and previous stool tests experiences. For both tests, limited medical record reminders was a major barrier. Facilitator themes for both tests included community outreach, cultural competency and patient navigation, and clinic/system improvements. In-depth interviews with tribal health providers showed that adding mt-sDNA testing may help address system-level colonoscopy barriers such as waitlists and travel costs, but other barriers remain. Further research is needed into patient barriers and facilitators, as well as the effectiveness of integrating mt-sDNA into a geographically dispersed tribal health system to reduce cancer disparities and build equity in CRC prevention among Alaska Native people.

show abstract

Development of a colorectal cancer screening intervention for Alaska Native people during a pandemic year

Cited by 3 publications

References 29 publications

Clinical Outcomes from the Alaska Native Tribal Health Consortium Colorectal Cancer Control Program: 2009–2015

Clinical Outcomes from the Alaska Native Tribal Health Consortium Colorectal Cancer Control Program: 2009–2015

Colorectal cancer screening future modalities among Saudi population: national questioner

Provider- and System-Level Barriers and Facilitators to Colonoscopy and Multi-Target Stool DNA for Colorectal Cancer Screening in Rural/Remote Alaska Native Communities

Contact Info

Product

Resources

About